Inventor · disambiguated record
Adolfo A. Ferrando
Also filed as: FERRANDO ADOLFO · FERRANDO ADOLFO A
5 granted patents·3 pending applications·14 citations·filing 2005–2021
71Inventor score
Files withUNIV COLUMBIA4ASTER JON C1DANA FARBER CANCER INST INC1FERRANDO ADOLFO A1WENDEL HANS-GUIDO1
Top patents by PatentIndex Score
8 records- 0185US9574241B2Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T-cell lymphomasUNIV COLUMBIA·Filed 2014·Granted Feb 21, 2017·11 cites·5 claims
- 0263US8633179B2Synergistic interaction of NOTCH-1 inhibitors with glucocorticoidsFERRANDO ADOLFO A·Filed 2008·Granted Jan 21, 2014·2 cites·14 claims
- 0361US12377107B2NT5C2 inhibitors for the treatment of chemotherapy-resistant acute lymphoblastic leukemiaUNIV COLUMBIA·Filed 2021·Granted Aug 5, 2025·0 cites·17 claims
- 0460US8716233B2NOTCH mutations leading to increased receptor signalingASTER JON C·Filed 2009·Granted May 6, 2014·1 cites·20 claims
- 0544US2015299801A1Techniques for Treating Acute Lymphoblastic Leukemia (ALL)UNIV COLUMBIA·Filed 2013·Application pending·0 cites
- 0643US2007077245A1NOTCH mutations leading to increased receptor signalingDANA FARBER CANCER INST INC·Filed 2005·Application pending·0 cites
- 0741US2011118192A1Methods and compositions for treating t-cell leukemiaUNIV COLUMBIA·Filed 2008·Application pending·0 cites
- 0827US9624491B2Methods and compositions for the detection and treatment of cancer involving miRNAs and miRNA inhibitors and targetsWENDEL HANS-GUIDO·Filed 2011·Granted Apr 18, 2017·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →